Discordance in HIV‐1 Co‐receptor use prediction by different genotypic algorithms and phenotype assay: Intermediate profile in relation to concordant predictions
暂无分享,去创建一个
P. André | L. Cotte | C. Scholtès | T. Perpoint | M. Trabaud | V. Icard | D. Makhloufi | J. Koffi | J. Tardy | Jean Claude Tardy
[1] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[2] A. Wensing,et al. European guidelines on the clinical management of HIV-1 tropism testing. , 2011, The Lancet. Infectious diseases.
[3] V. Calvez,et al. Concordance between Two Phenotypic Assays and Ultradeep Pyrosequencing for Determining HIV-1 Tropism , 2011, Antimicrobial Agents and Chemotherapy.
[4] Jeroen Aerssens,et al. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. , 2011, Antiviral research.
[5] Alexander Thielen,et al. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients. , 2011, The Journal of infectious diseases.
[6] L. Stuyver,et al. Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment , 2010, The Journal of antimicrobial chemotherapy.
[7] F. Gutiérrez,et al. Performance of Genotypic Algorithms for Predicting HIV-1 Tropism Measured against the Enhanced-Sensitivity Trofile Coreceptor Tropism Assay , 2010, Journal of Clinical Microbiology.
[8] C. Petropoulos,et al. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors , 2010, AIDS.
[9] J. Izopet,et al. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists , 2010 .
[10] Andrew J. Low,et al. Improved Detection of CXCR4-Using HIV by V3 Genotyping: Application of Population-Based and “Deep” Sequencing to Plasma RNA and Proviral DNA , 2010, Journal of acquired immune deficiency syndromes.
[11] F. Baldanti,et al. Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group. , 2010, The new microbiologica.
[12] M. Prosperi,et al. Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping , 2010, Retrovirology.
[13] P. Gorry,et al. Constrained use of CCR5 on CD4+ lymphocytes by R5X4 HIV-1: efficiency of Env-CCR5 interactions and low CCR5 expression determine a range of restricted CCR5-mediated entry. , 2010, Virology.
[14] C. Charpentier,et al. Evaluation of the Genotypic Prediction of HIV-1 Coreceptor Use versus a Phenotypic Assay and Correlation with the Virological Response to Maraviroc: the ANRS GenoTropism Study , 2010, Antimicrobial Agents and Chemotherapy.
[15] E. Fenyö,et al. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[16] L. Stuyver,et al. HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays , 2010, AIDS research and therapy.
[17] E. Poveda,et al. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists—authors’ response , 2010 .
[18] Thomas Lengauer,et al. V3 Loop Sequence Space Analysis Suggests Different Evolutionary Patterns of CCR5- and CXCR4-Tropic HIV , 2009, PloS one.
[19] H. Schuitemaker,et al. Comparison of Human Immunodeficiency Virus Type 1 Tropism Profiles in Clinical Samples by the Trofile and MT-2 Assays , 2009, Antimicrobial Agents and Chemotherapy.
[20] M. Sagar,et al. Human Immunodeficiency Virus Type 1 V1-to-V5 Envelope Variants from the Chronic Phase of Infection Use CCR5 and Fuse More Efficiently than Those from Early after Infection , 2009, Journal of Virology.
[21] M. Hughes,et al. Assessing Human Immunodeficiency Virus Type 1 Tropism: Comparison of Assays Using Replication-Competent Virus versus Plasma-Derived Pseudotyped Virions , 2009, Journal of Clinical Microbiology.
[22] P. Massip,et al. Genotypic Prediction of Human Immunodeficiency Virus Type 1 CRF02-AG Tropism , 2009, Journal of Clinical Microbiology.
[23] Natalia Chueca,et al. Improvement in the determination of HIV‐1 tropism using the V3 gene sequence and a combination of bioinformatic tools , 2009, Journal of medical virology.
[24] E. Poveda,et al. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists. , 2009, The Journal of antimicrobial chemotherapy.
[25] J. Mullins,et al. Evolution of CCR5 Use before and during Coreceptor Switching , 2008, Journal of Virology.
[26] M. Churchill,et al. Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge. , 2008, Virology.
[27] L. Cuzin,et al. Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism , 2008, AIDS.
[28] E. Poveda,et al. Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters , 2008, Journal of Acquired Immune Deficiency Syndromes.
[29] L. Stuyver,et al. Minor Variant Detection at Different Template Concentrations in HIV-1 Phenotypic and Genotypic Tropism Testing , 2008, The open virology journal.
[30] Andrew J. Low,et al. CD4-dependent characteristics of coreceptor use and HIV type 1 V3 sequence in a large population of therapy-naive individuals. , 2008, AIDS research and human retroviruses.
[31] Natalia Chueca,et al. Evaluation of Eight Different Bioinformatics Tools To Predict Viral Tropism in Different Human Immunodeficiency Virus Type 1 Subtypes , 2008, Journal of Clinical Microbiology.
[32] V. Calvez,et al. Comparison of two genotypic algorithms to determine HIV‐1 tropism * , 2008, HIV medicine.
[33] L. Scudeller,et al. HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples. , 2007, Virus research.
[34] Andrew J. Low,et al. Predicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates , 2007, Antiviral therapy.
[35] Tobias Sing,et al. Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates , 2007, AIDS.
[36] E. Poveda,et al. Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use , 2007, AIDS.
[37] Wei Huang,et al. Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations , 2007, Journal of Virology.
[38] J. Reeves,et al. Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching , 2007, Journal of Virology.
[39] Kevin C. Olivieri,et al. The envelope gene is a cytopathic determinant of CCR5 tropic HIV-1. , 2007, Virology.
[40] Tobias Sing,et al. Determining Human Immunodeficiency Virus Coreceptor Use in a Clinical Setting: Degree of Correlation between Two Phenotypic Assays and a Bioinformatic Model , 2006, Journal of Clinical Microbiology.
[41] Christos J. Petropoulos,et al. Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism , 2006, Antimicrobial Agents and Chemotherapy.
[42] B. Clotet,et al. Purifying selection of CCR5-tropic human immunodeficiency virus type 1 variants in AIDS subjects that have developed syncytium-inducing, CXCR4-tropic viruses. , 2006, The Journal of general virology.
[43] Helen Piontkivska,et al. HIV type 1 tropism and inhibitors of viral entry: clinical implications. , 2006, AIDS reviews.
[44] B. Gazzard,et al. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection. , 2005, The Journal of infectious diseases.
[45] John P. Moore,et al. The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. , 2004, AIDS research and human retroviruses.
[46] J. Margolick,et al. Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences , 2003, Journal of Virology.
[47] Jacques Corbeil,et al. A new perspective on V3 phenotype prediction. , 2003, AIDS research and human retroviruses.
[48] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.